MCL-1 inhibition in cancer treatment
Weiguo Xiang,1 Chao-Yie Yang,1,2 Longchuan Bai1,2 1Department of Internal Medicine, University of Michigan Medical School, 2Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA Abstract: Myeloid cell leukemia-1 (MCL-1), a member of antiapoptotic BCL-2 family proteins, is a key regulator...
Main Authors: | Xiang W, Yang CY, Bai L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mcl-1-inhibition-in-cancer-treatment-peer-reviewed-article-OTT |
Similar Items
-
Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy
by: Hoda Sobhy Ibrahim, et al.
Published: (2019-12-01) -
Targeting BCL-2 regulated apoptosis in cancer
by: Kirsteen J. Campbell, et al.
Published: (2018-05-01) -
Logical complexity of Bcl-2 family proteins function in the intrinsic apoptosis
by: Adamkov Marian
Published: (2019-01-01) -
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
by: David J. Mallick, et al.
Published: (2020-08-01) -
Poxviral manipulation of Bcl-2 proteins: fowlpox virus FPV039 and deerpox virus DPV022 inhibit apoptosis by neutralising Bak and Bax, while Noxa contributes to vaccinia virus-induced apoptosis
by: Banadyga, Logan Elliott
Published: (2011)